Company Overview
Position Overview
The Contract Senior Recruiter, Life Sciences will support Immunome’s growing Clinical/Development and Commercial organizations by leading full-cycle recruitment for a broad range of roles across the organization. This position will partner closely with a variety of teams to attract, assess, and hire high-quality talent in a competitive oncology biotech environment. Solid demonstrated candidate sourcing experience is required.
The ideal candidate is a proactive, detail-oriented recruiter with experience supporting clinical-stage life sciences organizations and managing multiple complex requisitions simultaneously.
Responsibilities
- Lead full-cycle recruitment for a variety of clinical and development-focused roles, including sourcing, screening, interviewing, and offer coordination.
- Partner closely with hiring managers and HR to understand evolving business needs, role requirements, and hiring priorities.
- Develop and execute proactive sourcing strategies to identify qualified candidates with experience in oncology drug development and clinical research environments.
- Conduct in-depth candidate interviews to assess technical qualifications, cultural fit, and alignment with Immunome’s values.
- Coordinate interview logistics, gather feedback, and facilitate timely hiring decisions.
- Ensure a high quality and consistent candidate experience throughout the recruitment process.
- Maintain accurate and compliant records within the applicant tracking system (Greenhouse).
- Provide market insights related to talent availability, compensation trends, and competitive intelligence.
- Support contract and contingent workforce hiring needs as required.
Qualifications
- Bachelor’s degree or equivalent combination of education and experience.
- A minimum of 5 years of full-cycle recruiting experience is required, a blend of in-house and agency experience is preferred.
- Demonstrated experience recruiting Clinical/Development or Commercial focused roles within biotech, pharmaceutical, or CRO environments.
- Proven ability to manage multiple requisitions in a fast-paced, high-growth environment.
- Ability to work on-site in Bothell a minimum of one day per week.
Knowledge and Skills
- Strong understanding of research, clinical research, clinical development, and drug development functions within an oncology-focused organization, preferred.
- Experienced utilizing a variety of candidate sourcing tools and platforms.
- Excellent interpersonal, communication, and stakeholder management skills.
- Strong organizational skills with a high attention to detail.
- Ability to work independently while collaborating effectively across cross-functional teams.
E/E/O
Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
E-Verify
Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).
Skills Required
- Bachelor's degree or equivalent combination of education and experience
- Minimum 5 years of full-cycle recruiting experience
- Demonstrated experience recruiting Clinical/Development or Commercial roles in biotech, pharma, or CROs
- Solid demonstrated candidate sourcing experience and use of sourcing tools/platforms
- Experience maintaining accurate and compliant records in an applicant tracking system (Greenhouse)
- Proven ability to manage multiple requisitions in a fast-paced, high-growth environment
- Ability to work on-site in Bothell a minimum of one day per week
- Strong understanding of research, clinical research, clinical development, and drug development functions within oncology (preferred)
- Excellent interpersonal, communication, and stakeholder management skills
- Strong organizational skills with high attention to detail
- Ability to work independently while collaborating across cross-functional teams
What We Do
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.
